Plasma mRNA concentrations of placenta-specific 1 (PLAC1) and pregnancy associated plasma protein A (PAPP-A) are higher in early-onset than late-onset pre-eclampsia

Journal of Obstetrics and Gynaecology Research

Volumn 37, Issue 4, 2011, Pages 313-318

  Kodama, Miho ^a   Miyoshi, Hiroshi ^b   Fujito, Naoya ^b   Samura, Osamu ^c   Kudo, Yoshiki ^a  

^a HIROSHIMA PREFECTURAL HOSPITAL   (Japan)

^b ONOMICHI GENERAL HOSPITAL   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION   (Japan)

Author keywords

Cell free plasma mRNA; Early onset pre eclampsia; PAPP A; PLAC1; Placenta

Indexed keywords

MESSENGER RNA; PLACENTA SPECIFIC 1 PROTEIN; PREGNANCY ASSOCIATED PLASMA PROTEIN A; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EARLY ONSET PREECLAMPSIA; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LATE ONSET PREECLAMPSIA; MATERNAL PLASMA; PLACENTA; PREECLAMPSIA; PREGNANT WOMAN; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION;

ADULT; BIOLOGICAL MARKERS; FEMALE; HUMANS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY PROTEINS; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; RNA, MESSENGER;

EID: 79956099954     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2010.01349.x     Document Type: Article

References (12)

1. Walker JJ. Pre-eclampsia. Lancet 2000; 356: 1260-1265.
2. Meekins JW, Pijnenborg R, Hanssens M, McFadyen IR, van Asshe A. A study of placental bed spiral arteries and tropho-blast invasion in normal and severe pre-eclamptic pregnan-cies. Br J Obstet Gynaecol 1994; 101: 669-674. (Pubitemid 24251519)
3. Farina A, Sekizawa A, Purwosunu Y et al. Quantitative distribution of a panel of circulating mRNA in preeclampsia versus controls. Prenat Diagn 2006; 26: 1115-1120. (Pubitemid 44935273)
4. Okazaki S, Sekizawa A, Purwosunu Y, Farina A, Wibowo N, Okai T. Placenta-derived, cellular messenger RNA expres-sion in the maternal blood of preeclamptic women. Obstet Gynecol 2007; 110: 1130-1136. (Pubitemid 350059420)
5. Purwosunu Y, Sekizawa A, Farina Aetal. Evaluation of physi-ological alterations of the placenta through analysis of cell-free messenger ribonucleic acid concentrations of angiogenic factors. Am J Obstet Gynecol 2008; 198: e1-e7.
6. Fujito N, Samura O, Miharu N, Tanigawa M, Hyodo M, Kudo Y. Increased plasma mRNAs of placenta-specific 1 (PLAC1) and glial cells-missing 1 (GCM1) in mothers with pre-eclampsia. Hiroshima J Med Sci 2006; 55: 9-15.
7. Ng EK, Tsui NB, Lam NY et al. Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals. Clin Chem 2002; 48: 1212-1217. (Pubitemid 34809828)
8. Ng EK, Tsui NB, Lau TK et al. mRNA of placental origin is readily detectable in maternal plasma. Proc Natl Acad Sci USA 2003; 100: 4748-4753. (Pubitemid 36457801)
9. Purwosunu Y, Sekizawa A, Farina A et al. Cell-free mRNA concentrations of CRH, PLAC1, and selectin-P are increased in the plasma of pregnant women with preeclampsia. Prenat Diagn 2007; 27: 772-777. (Pubitemid 47242409)
10. Bersinger NA, Smarason AK, Muttukrishna S, Groome NP, Redman CW. Women with preeclampsia have increased serum levels of pregnancy-associated plasma protein A (PAPP-A), inhibin A, activin A and soluble E-selectin. Hyper-tens Pregnancy 2003; 22: 45-55. (Pubitemid 36205807)
11. Spencer K, Yu CK, Savvidou M, Papageorghiou AT, Nico-laides KH. Prediction of pre-eclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy-associated plasma protein-A, free beta-human chorionic gonadotropin, activin A and inhibin A at 22 + 0 to 24 + 6 weeks' gestation. Ultrasound Obstet Gynecol 2006; 27: 658-663. (Pubitemid 43967369)
12. Lau TW, Leung TN, Chan LY et al. Fetal DNA clearance from maternal plasma is impaired in preeclampsia. Clin Chem 2002; 48: 2141-2146. (Pubitemid 35397555)